Official UK procurement notice
QHM-2025-9921 · UK public procurement notice
Authority: NHS North East and North Cumbria Integrated Care Board (Central government)
What is being bought
Published requirement descriptionNear Patient Testing (High Risk) Drug Monitoring
Warfarin Monitoring
Hormonal Injection Administration Service
Minor Injuries
The contract value cannot be confirmed as the services are activity based contracts with no guaranteed contract value'
The relevant authority intends to award this contract under the Direct Award Process A under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 and Procurement Regulations 2024 do not apply to this award.
The contract value is £0.01.
Contract Start Date: 01 April 2025
Contract End Date: 31 March 2026
Although the contract start is 01/04/2025, the services have been delivered on an implied contract.
This is an existing service and existing provider.
CPV: Health services
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 9 Oct 2025, 21:54 BST
- Last source update
- 10 Oct 2025, 14:09 BST
- Authority reference
QHM-2025-9921 Aspatria Medical Group- Local Enhanced Services- FTS notice number
2025/S 000-064198- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-05ac38Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
The relevant authority intends to award this contract under the Direct Award Process A under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 and Procurement Regulations 2024 do not apply to this award.
Publisher note: The relevant authority intends to award this contract under the Direct Award Process A under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 and Procurement Regulations 2024 do not apply to this award. Details of the individual(s) making the award decision: Chief Delivery Officer Director of Finance Director of Finance Director to Finance Conflicts of interest were managed throughout the process and there were no conflicts of interests identified.
Notice history
3 releases on Find a TenderPublished amendments (1)
This is a correction to the original notice of services this provider is delivering. Near Patient Testing (High Risk) Drug Monitoring Warfarin Monitoring Hormonal Injection Administration Service Minor Injuries
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Aspatria Medical GroupQHM-2025-9921 Aspatria Medical Group- Local Enhanced Services | £0 † | — | Awarded |
| Aspatria Medical Group, Parkway Medical Groupjoint awardQHM-2025-9921 Aspatria Medical Group- Local Enhanced Services | £0 † | — | Awarded |
Contracts
QHM-2025-9921 Aspatria Medical Group- Local Enhanced Services · Aspatria Medical Group
- Signed
- 1 Oct 2025
- Value
- £0
- Status
- active
QHM-2025-9921 Aspatria Medical Group- Local Enhanced Services · Aspatria Medical Group, Parkway Medical Group
- Signed
- 1 Oct 2025
- Value
- £0
- Status
- active
- Change Description of services, Need for additional works, services or supplies by the original contractor/concessionaire: Near Patient Testing (High Risk) Drug Monitoring Warfarin Monitoring Hormonal Injection Administration Service Minor Injuries The contract value cannot be confirmed as the services are activity based contracts with no guaranteed contract value. The relevant authority intends to award this contract under the Direct Award Process A under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 and Procurement Regulations 2024 do not apply to this award. The contract value is £0.01. Contract Start Date: 01 April 2025 Contract End Date: 31 March 2026 Although the contract start is 01/04/2025, the services have been delivered on an implied contract. This is an existing service and existing provider.
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- North East and North Cumbria Integrated Care BoardReview body
Bidders & participating suppliers
1 commercial party on the notice- Aspatria Medical GroupAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.